Fisher Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Sell |
822,208
-49,420
| -6% | -$1.01M | 0.01% | 343 |
|
|
2025
Q1 | $15.8M | Buy |
871,628
+419,131
| +93% | +$7.61M | 0.01% | 353 |
|
|
2024
Q4 | $11.4M | Buy |
452,497
+78,145
| +21% | +$1.97M | ﹤0.01% | 416 |
|
|
2024
Q3 | $12.7M | Buy |
374,352
+253,808
| +211% | +$8.63M | 0.01% | 389 |
|
|
2024
Q2 | $4.46M | Sell |
120,544
-3,292
| -3% | -$122K | ﹤0.01% | 498 |
|
|
2024
Q1 | $5.2M | Buy |
123,836
+102,024
| +468% | +$4.28M | ﹤0.01% | 502 |
|
|
2023
Q4 | $865K | Buy |
21,812
+1,274
| +6% | +$50.5K | ﹤0.01% | 710 |
|
|
2023
Q3 | $565K | Hold |
20,538
| – | – | ﹤0.01% | 835 |
|
|
2023
Q2 | $697K | Hold |
20,538
| – | – | ﹤0.01% | 833 |
|
|
2023
Q1 | $739K | Sell |
20,538
-8,479
| -29% | -$305K | ﹤0.01% | 806 |
|
|
2022
Q4 | $1.29M | Sell |
29,017
-4,876
| -14% | -$217K | ﹤0.01% | 723 |
|
|
2022
Q3 | $953K | Buy |
+33,893
| New | +$953K | ﹤0.01% | 680 |
|